Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Pain in Sickle Cell VOC
NCT01954927Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Oct 2013
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in sickle cell disease (SCD), sponsored by St. Jude Children's Research Hospital. Started Oct 2013; status: completed.
02
Drugs
gabapentin
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01954927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01954927.